LCM
SAGE

Landscape Capital Management’s Sage Therapeutics SAGE Stock Holding History

Landscape Capital Management’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-35,301
Closed -$765K – 950
2023
Q4 		$765K Buy
+35,301
New +$700K 0.07% 284
2014
Q4 		– Sell
-22,116
Closed -$697K – 586
2014
Q3 		$697K Buy
+22,116
New +$641K 0.48% 50

Other funds holding SAGE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Landscape Capital Management's SAGE Position: Q1 2024 in Review

Landscape Capital Management sold out of Sage Therapeutics (SAGE) in Q1 2024, closing a stake of 35,301 shares — an estimated $765K sold.

Landscape Capital Management first reported a position in SAGE in Q3 2014 and held it in 2 quarters. The position peaked at $765K in Q4 2023. 204 funds tracked by Wall St. Rank hold SAGE as of Q1 2024.

  • Landscape Capital Management reported no remaining Sage Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Landscape Capital Management sold 35,301 Sage Therapeutics shares in Q1 2024, an estimated $765K.
  • Landscape Capital Management first reported a position in Sage Therapeutics in Q3 2014 and held it in 2 quarters.
  • Landscape Capital Management's Sage Therapeutics position peaked at $765K in Q4 2023.
  • 204 funds tracked by Wall St. Rank held Sage Therapeutics as of Q1 2024.

Based on Landscape Capital Management's 13F filing for Q1 2024, filed 9 May 2024.